Furthermore, the TET1 exhibited the highest mutation frequency in LIHC, READ, and STAD, while TET3 and DNMT3A were the most frequent in COAD and PAAD, respectively (Figure 1e). This evidence concerns the gene TET1 and pancreatic adenocarcinoma.